We provide you with 20 years of free, institutional-grade data for TNYA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TNYA. Explore the full financial landscape of TNYA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Ali Faraz | Grant, award...etc | 85,000 | 2024-02-27 | ||
| Hoey Timothy | Grant, award...etc | 12,500 | 2024-02-27 | ||
| PATTERSON LEONE D | Grant, award...etc | 35,000 | 2024-02-27 | ||
| Tingley Whittemore | Grant, award...etc | 35,000 | 2024-02-27 | ||
| Hoey Timothy | Sale | -6,569 | $5.31 | $34,875 | 2024-02-21 |
| Hoey Timothy | Sale | -4,681 | $5.86 | $27,431 | 2024-02-16 |
| Tingley Whittemore | Sale | -6,500 | $5.86 | $38,090 | 2024-02-16 |
| PATTERSON LEONE D | Sale | -5,201 | $5.86 | $30,478 | 2024-02-16 |
| Ali Faraz | Sale | -6,358 | $5.86 | $37,258 | 2024-02-16 |
| COLUMN GROUP III GP, LP | Open Market Purchase | 2,222,222 | $4.5 | 2024-02-14 | |
| GOEDDEL DAVID V | Open Market Purchase | 2,222,222 | $4.5 | 2024-02-14 | |
| Hoey Timothy | Sale | -7,243 | $4.26 | $30,855 | 2023-08-29 |
| Tingley Whittemore | Sale | -5,563 | $3.81 | $21,195 | 2023-08-18 |
| Hoey Timothy | Sale | -4,007 | $3.81 | $15,267 | 2023-08-18 |
| PATTERSON LEONE D | Sale | -4,452 | $3.81 | $16,962 | 2023-08-18 |
| Ali Faraz | Sale | -5,563 | $3.81 | $21,195 | 2023-08-18 |
| GOEDDEL DAVID V | Open Market Purchase | 6,779 | $2.6 | 2023-03-14 | |
| COLUMN GROUP III GP, LP | Open Market Purchase | 6,779 | $2.6 | 2023-03-14 | |
| Tingley Whittemore | Grant, award...etc | 80,000 | 2023-02-17 | ||
| Hoey Timothy | Grant, award...etc | 60,000 | 2023-02-17 | ||
| Ali Faraz | Grant, award...etc | 125,000 | 2023-02-17 | ||
| PATTERSON LEONE D | Grant, award...etc | 65,000 | 2023-02-17 | ||
| GOEDDEL DAVID V | Open Market Purchase | 1,500,000 | $2.6 | 2023-02-10 | |
| COLUMN GROUP III GP, LP | Open Market Purchase | 1,500,000 | $2.6 | 2023-02-10 | |
| COLUMN GROUP III GP, LP | Open Market Purchase | 69,739 | $2.5 | 2023-01-23 | |
| GOEDDEL DAVID V | Open Market Purchase | 69,739 | $2.5 | 2023-01-23 | |
| COLUMN GROUP III GP, LP | Open Market Purchase | 185,151 | $2.49 | 2023-01-19 | |
| GOEDDEL DAVID V | Open Market Purchase | 185,151 | $2.49 | 2023-01-19 | |
| Srivastava Deepak | Open Market Purchase | 230,769 | $2.6 | 2022-12-09 | |
| Casdin Eli | Open Market Purchase | 2,492,042 | $2.6 | 2022-11-25 | |
| GOEDDEL DAVID V | Open Market Purchase | 9,615,384 | $2.6 | 2022-11-23 | |
| COLUMN GROUP III GP, LP | Open Market Purchase | 9,615,384 | $2.6 | 2022-11-23 | |
| Hoey Timothy | Sale | -1,353 | $10.13 | $13,706 | 2022-04-28 |
| Casdin Partners Master Fund, L.P. | Open Market Purchase | 850,000 | $15 | 2021-08-04 | |
| Casdin Eli | Open Market Purchase | 850,000 | $15 | 2021-08-04 | |
| Hoey Timothy | Initial | 2021-07-29 | |||
| Srivastava Deepak | Initial | 2021-07-29 | |||
| Williams R Sanders | Initial | 2021-07-29 | |||
| CHEN JIN-LONG | Initial | 2021-07-29 | |||
| Stehman-Breen Catherine | Initial | 2021-07-29 | |||
| Kang JeenJoo | Initial | 2021-07-29 |
The information provided in this report about TNYA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tenaya Therapeutics(NASDAQ:TNYA) 
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a ...
Website: http://www.tenayatherapeutics.com
Founded: 2016
CEO: Faraz Ali
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends